<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-19T23:36:08+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>礼来、豪森两款降糖药公布谈判价格，降幅超50%，市场格局将大变！这款国产新药一同进入医保却受到质疑……</title>
    <updated>2021-01-19T21:27:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/CXQiyT1mMCk8uJ0GG2iO6Q</id>
    <link href="https://mp.weixin.qq.com/s/CXQiyT1mMCk8uJ0GG2iO6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅国际创新药VASCEPA®登陆海南，撬动中国心血管领域“后他汀”时代</title>
    <updated>2021-01-19T21:27:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/f3MILobLOq0rcMdmFEEn5g</id>
    <link href="https://mp.weixin.qq.com/s/f3MILobLOq0rcMdmFEEn5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一万年太久，做好产品只争朝夕！</title>
    <updated>2021-01-19T21:27:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/PyIhBqb8YkDCyVujFggEQA</id>
    <link href="https://mp.weixin.qq.com/s/PyIhBqb8YkDCyVujFggEQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫情之下，2021年全球生物医药行业七大趋势预测！下一个风口在这里！</title>
    <updated>2021-01-18T20:49:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/qwK4piPaGwxJHHDVeRGuAg</id>
    <link href="https://mp.weixin.qq.com/s/qwK4piPaGwxJHHDVeRGuAg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝康医疗：基因检测创新引领者 独具先发优势</title>
    <updated>2021-01-18T20:49:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/E39G7KpqlR4GBEn9ElssrA</id>
    <link href="https://mp.weixin.qq.com/s/E39G7KpqlR4GBEn9ElssrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>看跨国药企如何玩转零售，益普生签约保健食品</title>
    <updated>2021-01-18T20:49:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/D5B85jNd6IrU20eNjnHSrw</id>
    <link href="https://mp.weixin.qq.com/s/D5B85jNd6IrU20eNjnHSrw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球53.3%临床在中国！首款国产CAR-T即将上市，高昂定价谁来买单？</title>
    <updated>2021-01-17T20:02:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/HjDVPNw2lASvjCvUQVGa4Q</id>
    <link href="https://mp.weixin.qq.com/s/HjDVPNw2lASvjCvUQVGa4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>估值回调，上市套利时代结束，分拆继续，投资人眼中的2021</title>
    <updated>2021-01-17T20:02:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/dIHocSJuYf-WRPoQWIgYfw</id>
    <link href="https://mp.weixin.qq.com/s/dIHocSJuYf-WRPoQWIgYfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>普瑞基准通过中国前列腺癌HRR检测校准计划</title>
    <updated>2021-01-17T20:02:07+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/x1NeVnUnQ4PYsII3yrlPUQ</id>
    <link href="https://mp.weixin.qq.com/s/x1NeVnUnQ4PYsII3yrlPUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安进中国:深挖本土需求，打开在华加速新局面</title>
    <updated>2021-01-16T17:31:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/wAPQxeiKrJ26BywRVyO2Vw</id>
    <link href="https://mp.weixin.qq.com/s/wAPQxeiKrJ26BywRVyO2Vw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安进：四十载创新变革—布局全球，加速中国正当时</title>
    <updated>2021-01-16T17:31:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/lZbmXWlTkH49jWhpGQO2bw</id>
    <link href="https://mp.weixin.qq.com/s/lZbmXWlTkH49jWhpGQO2bw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>柯美玲：每个女性用自己力量改变世界的故事都令人振奋</title>
    <updated>2021-01-16T17:31:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/CBd0p_ikpCkR4pc3kEPzqw</id>
    <link href="https://mp.weixin.qq.com/s/CBd0p_ikpCkR4pc3kEPzqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【秋实观点】医疗投资：精彩纷呈的隐形冠军</title>
    <updated>2021-01-16T17:31:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/aY92Xw2pmas8WYGYwjltSQ</id>
    <link href="https://mp.weixin.qq.com/s/aY92Xw2pmas8WYGYwjltSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批集采下月初开标！少10个品规，齐鲁、扬子江、石药本土TOP3，AZ、诺华、BI涉超多品种</title>
    <updated>2021-01-15T18:59:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/_OKxWxOSob5Oa5EPwLCXFA</id>
    <link href="https://mp.weixin.qq.com/s/_OKxWxOSob5Oa5EPwLCXFA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>铁娘子Janet Woodcock或接任FDA局长，新药审批有望加速？</title>
    <updated>2021-01-15T18:59:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/fKHa_YY8AioWNOVl3YGoNw</id>
    <link href="https://mp.weixin.qq.com/s/fKHa_YY8AioWNOVl3YGoNw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>具有奇特“融合基因”的艾力斯能走多远?</title>
    <updated>2021-01-15T18:59:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/oBRW07JtqZE7a7wvmqBJWQ</id>
    <link href="https://mp.weixin.qq.com/s/oBRW07JtqZE7a7wvmqBJWQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>艾伯维下个“修美乐”在哪？武田要继续“卖”到何时？巨无霸药企们如何保住自身“地位”？</title>
    <updated>2021-01-14T21:22:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/8SjxQJ2cQnTdGL75Sn_g6g</id>
    <link href="https://mp.weixin.qq.com/s/8SjxQJ2cQnTdGL75Sn_g6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国首个! 瑞欣妥®在华重磅获批 绿叶制药创新微球技术展现全球领先优势</title>
    <updated>2021-01-14T21:22:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/6jmEYDSf-PIOUi3quMpqvA</id>
    <link href="https://mp.weixin.qq.com/s/6jmEYDSf-PIOUi3quMpqvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>12种商业化产品，百济生猛！靠ADC惊艳全场，玩转授权引进，瞄准补体靶向疗法，荣昌、再鼎、万春、亚盛.....亮相JPM大会</title>
    <updated>2021-01-14T21:22:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/PaZIUQu0Y044C8Cg8o8dPw</id>
    <link href="https://mp.weixin.qq.com/s/PaZIUQu0Y044C8Cg8o8dPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“三驾马车”遭生物类似药围攻、蓝药丸消失，罗氏、辉瑞两大巨头掌门人回应下一步怎么做？</title>
    <updated>2021-01-13T21:29:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/QsxAL5Boyl40V3UqcWcsmA</id>
    <link href="https://mp.weixin.qq.com/s/QsxAL5Boyl40V3UqcWcsmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>